Dog Immune Thrombocytopenia: Follow-Up Care

Immune-mediated thrombocytopenia in dogs is a serious autoimmune disorder causing platelet destruction, requiring careful long-term monitoring to prevent relapse.

Key Facts

Primary immune-mediated thrombocytopenia is one of the most common immune disorders in dogs
Platelet counts below 30,000 per microliter create serious hemorrhage risk
Most dogs respond to immunosuppressive doses of prednisolone within two weeks
Relapse occurs in approximately 20-40% of dogs after initial treatment
Splenectomy is considered for refractory cases as a second-line option

Welfare Considerations

Dogs with immune-mediated thrombocytopenia experience significant distress from spontaneous bleeding including petechiae, nosebleeds, and blood in urine or stool. The condition requires prolonged immunosuppressive treatment with its own side effects including increased thirst, urination, appetite, and infection susceptibility. Long-term follow-up with regular platelet counts helps detect early relapse before life-threatening hemorrhage occurs, minimizing preventable suffering.

What You Can Do

Schedule regular complete blood counts every 1-3 months during remission maintenance
Monitor dogs on immunosuppression for signs of infection which may be masked by medication
Avoid non-steroidal anti-inflammatory drugs and aspirin in dogs with history of this condition
Work with a veterinary internist for complex or refractory cases
Maintain a symptom diary to detect early signs of relapse such as lethargy or bruising